Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence.

Rurali E, Vinci MC, Bassetti B, Barbagallo V, Pompilio G, Gambini E.

Curr Stem Cell Res Ther. 2020 Feb 25. doi: 10.2174/1574888X15666200225124451. [Epub ahead of print]

PMID:
32096748
2.

Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients.

Perrucci GL, Rurali E, Corlianò M, Balzo M, Piccoli M, Moschetta D, Pini A, Gaetano R, Antona C, Egea G, Fischer G, Malešević M, Alamanni F, Cogliati E, Paolin A, Pompilio G, Nigro P.

Cells. 2020 Jan 8;9(1). pii: E154. doi: 10.3390/cells9010154.

3.

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes.

Valoti E, Noris M, Perna A, Rurali E, Gherardi G, Breno M, Parvanova Ilieva A, Petrov Iliev I, Bossi A, Trevisan R, Dodesini AR, Ferrari S, Stucchi N, Benigni A, Remuzzi G, Ruggenenti P.

Front Genet. 2019 Jul 26;10:681. doi: 10.3389/fgene.2019.00681. eCollection 2019.

4.

Sensitive and quantitative method to evaluate DNA methylation of the positive regulatory domains (PRDI, PRDII) and cAMP response element (CRE) in human endothelial nitric oxide synthase promoter.

Vigorelli V, Rurali E, Carugo S, Pompilio G, Vinci MC.

Nitric Oxide. 2019 Nov 1;92:41-48. doi: 10.1016/j.niox.2019.08.005. Epub 2019 Aug 14.

5.

Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients.

Rurali E, Perrucci GL, Gaetano R, Pini A, Moschetta D, Gentilini D, Nigro P, Pompilio G.

Theranostics. 2019 Apr 12;9(8):2224-2234. doi: 10.7150/thno.30714. eCollection 2019.

6.

Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.

Rurali E, Pilato CA, Perrucci GL, Scopece A, Stadiotti I, Moschetta D, Casella M, Cogliati E, Sommariva E, Pompilio G, Nigro P.

Int J Mol Sci. 2019 May 15;20(10). pii: E2403. doi: 10.3390/ijms20102403.

7.

Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO).

Bassetti B, Carbucicchio C, Catto V, Gambini E, Rurali E, Bestetti A, Gaipa G, Belotti D, Celeste F, Parma M, Righetti S, Biava L, Arosio M, Bonomi A, Agostoni P, Scacciatella P, Achilli F, Pompilio G.

Stem Cell Res Ther. 2018 Sep 14;9(1):235. doi: 10.1186/s13287-018-0969-z.

8.

Cardiac fibrosis in regenerative medicine: destroy to rebuild.

Perrucci GL, Rurali E, Pompilio G.

J Thorac Dis. 2018 Jul;10(Suppl 20):S2376-S2389. doi: 10.21037/jtd.2018.03.82. Review.

9.

Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its Solution.

Rurali E, Perrucci GL, Pilato CA, Pini A, Gaetano R, Nigro P, Pompilio G.

Prog Cardiovasc Dis. 2018 Sep - Oct;61(3-4):328-335. doi: 10.1016/j.pcad.2018.07.020. Epub 2018 Jul 21. Review.

10.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

11.

BM ageing: Implication for cell therapy with EPCs.

Rurali E, Bassetti B, Perrucci GL, Zanobini M, Malafronte C, Achilli F, Gambini E.

Mech Ageing Dev. 2016 Oct;159:4-13. doi: 10.1016/j.mad.2016.04.002. Epub 2016 Apr 1. Review.

PMID:
27045606
12.

Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

Perrucci GL, Rurali E, Gowran A, Pini A, Antona C, Chiesa R, Pompilio G, Nigro P.

Cell Mol Life Sci. 2017 Jan;74(2):267-277. doi: 10.1007/s00018-016-2324-9. Epub 2016 Aug 17. Review.

PMID:
27535662
13.

Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.

Pecoraro C, Ferretti AV, Rurali E, Galbusera M, Noris M, Remuzzi G.

Am J Kidney Dis. 2015 Dec;66(6):1067-70. doi: 10.1053/j.ajkd.2015.06.032. Epub 2015 Sep 26.

PMID:
26409664
14.

ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.

Rurali E, Banterla F, Donadelli R, Bresin E, Galbusera M, Gastoldi S, Peyvandi F, Underwood M, Remuzzi G, Noris M.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2002-12. doi: 10.2215/CJN.01700215. Epub 2015 Sep 4.

15.

ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.

Rurali E, Noris M, Chianca A, Donadelli R, Banterla F, Galbusera M, Gherardi G, Gastoldi S, Parvanova A, Iliev I, Bossi A, Haefliger C, Trevisan R, Remuzzi G, Ruggenenti P; BENEDICT Study Group.

Diabetes. 2013 Oct;62(10):3599-609. doi: 10.2337/db13-0530. Epub 2013 Jun 3.

16.

Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M; European Working Party on Complement Genetics in Renal Diseases.

J Am Soc Nephrol. 2013 Feb;24(3):475-86. doi: 10.1681/ASN.2012090884. Epub 2013 Feb 21.

17.

Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury.

Jamale TE, Hase NK, Kulkarni M, Iqbal AM, Rurali E, Kulkarni MG, Shetty P, Pradeep KJ.

Indian J Nephrol. 2012 Jul;22(4):298-300. doi: 10.4103/0971-4065.101257.

18.

Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations.

Prestidge TD, Rurali E, Wadsworth L, Wu JK, Moore JC, Bresin E.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1296-8. doi: 10.1002/pbc.24159. Epub 2012 Apr 5.

PMID:
22488907

Supplemental Content

Loading ...
Support Center